191 related articles for article (PubMed ID: 37693125)
21. Cross-talk among MEN1, p53 and Notch regulates the proliferation of pancreatic neuroendocrine tumor cells by modulating INSM1 expression and subcellular localization.
Capodanno Y; Chen Y; Schrader J; Tomosugi M; Sumi S; Yokoyama A; Hiraoka N; Ohki R
Neoplasia; 2021 Sep; 23(9):979-992. PubMed ID: 34352404
[TBL] [Abstract][Full Text] [Related]
22. Tumor-specific promoter-driven adenoviral therapy for insulinoma.
Tseng AW; Chen C; Breslin MB; Lan MS
Cell Oncol (Dordr); 2016 Jun; 39(3):279-86. PubMed ID: 26902080
[TBL] [Abstract][Full Text] [Related]
23. Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development.
Chen C; Breslin MB; Lan MS
BMC Pulm Med; 2016 Apr; 16():49. PubMed ID: 27072116
[TBL] [Abstract][Full Text] [Related]
24. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
25. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.
Wang HW; Breslin MB; Chen C; Akerstrom V; Zhong Q; Lan MS
Hum Gene Ther; 2009 Nov; 20(11):1308-18. PubMed ID: 19604042
[TBL] [Abstract][Full Text] [Related]
26. Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens.
Doxtader EE; Mukhopadhyay S
Cancer Cytopathol; 2018 Apr; 126(4):243-252. PubMed ID: 29360191
[TBL] [Abstract][Full Text] [Related]
27. Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective.
Kawasaki T; Kaira K
Virchows Arch; 2021 Jul; 479(1):191-194. PubMed ID: 33025295
[TBL] [Abstract][Full Text] [Related]
28. Insulinoma-associated protein 1 is a prognostic biomarker in pulmonary high-grade neuroendocrine carcinoma.
Minami K; Jimbo N; Tanaka Y; Ogawa H; Hokka D; Nishio W; Yoshimura M; Itoh T; Maniwa Y
J Surg Oncol; 2020 Aug; 122(2):243-253. PubMed ID: 32346887
[TBL] [Abstract][Full Text] [Related]
29. RNA binding protein HuD and microRNA-203a cooperatively regulate insulinoma-associated 1 mRNA.
Kim C; Ahn S; Lee EK
Biochem Biophys Res Commun; 2020 Jan; 521(4):971-976. PubMed ID: 31722792
[TBL] [Abstract][Full Text] [Related]
30. Insulinoma-associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts.
González I; Lu HC; Sninsky J; Yang C; Bishnupuri K; Dieckgraefe B; Cao D; Chatterjee D
Histopathology; 2019 Oct; 75(4):568-577. PubMed ID: 31077609
[TBL] [Abstract][Full Text] [Related]
31. A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
Chen C; Lan MS
Cell Signal; 2020 Dec; 76():109785. PubMed ID: 32966884
[TBL] [Abstract][Full Text] [Related]
32. Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3.
Osipovich AB; Long Q; Manduchi E; Gangula R; Hipkens SB; Schneider J; Okubo T; Stoeckert CJ; Takada S; Magnuson MA
Development; 2014 Aug; 141(15):2939-49. PubMed ID: 25053427
[TBL] [Abstract][Full Text] [Related]
33. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
34. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
[TBL] [Abstract][Full Text] [Related]
35. INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance.
Zhang Q; Dong Y; Zhou M; Guo Y; Lou L; Qu Z; Zheng Y; Duan Y
Biomed Res Int; 2022; 2022():1580410. PubMed ID: 36531655
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analyses of the expression profiles of INSM1, ATRX, DAXX and DLL3 in solid papillary carcinomas of the breast.
Yanai H; Ishida M; Yoshikawa K; Tsuta K; Sekimoto M; Sugie T
Oncol Lett; 2022 Apr; 23(4):137. PubMed ID: 35317025
[TBL] [Abstract][Full Text] [Related]
37. Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features.
Turkevi-Nagy S; Báthori Á; Böcz J; Krenács L; Cserni G; Kővári B
Pathol Oncol Res; 2021; 27():1610039. PubMed ID: 34764822
[No Abstract] [Full Text] [Related]
38. Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
Wang M; Abi-Raad R; Baldassarri R; Adeniran AJ; Cai G
Hum Pathol; 2021 Sep; 115():104-111. PubMed ID: 34216697
[TBL] [Abstract][Full Text] [Related]
39. Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix.
Kuji S; Endo A; Kubota M; Uekawa A; Kawakami F; Mikami Y; Koike J; Suzuki N
J Gynecol Oncol; 2023 Jan; 34(1):e1. PubMed ID: 36245222
[TBL] [Abstract][Full Text] [Related]
40. The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein.
Xie J; Cai T; Zhang H; Lan MS; Notkins AL
Genomics; 2002 Jul; 80(1):54-61. PubMed ID: 12079283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
